Get the Stockscreener App
89.33
0.07%
0.019
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $89.33, with a volume of 2.14M.
It is up +0.07% in the last 24 hours and up +1.26% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$89.31
Open:
$89.05
24h Volume:
2.14M
Relative Volume:
0.40
Market Cap:
$114.70B
Revenue:
$32.58B
Net Income/Loss:
$3.93B
P/E Ratio:
32.96
EPS:
2.71
Net Cash Flow:
$5.15B
1W Performance:
-1.05%
1M Performance:
+1.26%
6M Performance:
+9.40%
1Y Performance:
+23.17%
1-Day Range:
$88.61
$89.59
1-Week Range:
$88.61
$91.80
52-Week Range:
$69.32
$92.68
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
20 ON HATCH, LOWER HATCH STREET, DUBLIN
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Robeco Institutional Asset Management B.V. Buys 37,089 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Medtronic : New data adds to body of research demonstrating safety and effectiveness of atherectomy - Marketscreener.com
Global Guidewires Market Poised for Significant Growth: Surge in Minimally Invasive Procedures and Technological Advancements Drive Market toward USD 6,885.7 million by 2034 | FMI - GlobeNewswire Inc.
CORDA Investment Management LLC. Purchases 6,921 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic receives CE Mark for Evolut™ FX+ TAVI system for treatment of symptomatic severe aortic stenosis - Mynewsdesk
Medtronic plc (NYSE:MDT) Shares Bought by Janney Montgomery Scott LLC - MarketBeat
Gladstone Institutional Advisory LLC Has $2.43 Million Stock Holdings in Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic (MDT) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
CMS grants Transitional Pass-Through Payment for Medtronic Symplicity Spyral™ renal denervation catheter - Medtronic
Wound Care Industry Trends and Growth Opportunities, 2024-2029: A Forecasted $56.7 Billion Market Assessment with Exclusive Data on 60+ Companies3M, Braun, Cardinal Health, Convatec, Medtronic & More - Yahoo Finance
HM Payson & Co. Sells 5,769 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic PLC stock underperforms Thursday when compared to competitors - MarketWatch
Pinnacle Associates Ltd. Sells 12,975 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade) - Seeking Alpha
Medtronic PLC stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Medtronic Receives FDA Approval of Mapping and Ablation System and Catheter - Diagnostic and Interventional Cardiology
New York State Teachers Retirement System Trims Stake in Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic bags USFDA approval of Affera Mapping and Ablation System and Sphere-9 Catheter - Medical Dialogues
Endoscopes Market Future Business Opportunities 2024-2031 | - openPR
Medtronic's Q2 2025 Earnings: What to Expect - MSN
Medtronic PLC stock outperforms competitors despite losses on the day - MarketWatch
Medtronic’s Symplicity Spyral RDN system shows sustained BP reduction - Medical Device Network
Medtronic's Q2 2025 Earnings: What To Expect - Barchart
abrdn plc Has $116.28 Million Holdings in Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic (MDT) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Medtronic PLC stock rises Monday, still underperforms market - MarketWatch
SPYRAL HTN-ON MED study shows significant, consistent, long-term blood pressure lowering effect at two years - Medtronic
Medtronic : appoints Dr. Matthew Kroh as Chief Medical Officer for Advanced and General Surgical Technologies - Marketscreener.com
Medtronic plc (NYSE:MDT) Shares Purchased by Klein Pavlis & Peasley Financial Inc. - MarketBeat
Medtronic plc (NYSE:MDT) Shares Sold by State of Alaska Department of Revenue - MarketBeat
RBC Capital Markets upgrades Medtronic to 'outperform' on growth confidence - MSN
Medtronic plc (NYSE:MDT) Shares Acquired by International Assets Investment Management LLC - MarketBeat
Stifel downgrades Medtronic, citing delayed progress - MSN
Medtronic’s Affera PFA snags FDA approval - BioWorld Online
Can Medtronic plc's (NYSE:MDT) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price? - Simply Wall St
A New Paradigm in Electrophysiology: Medtronic Receives FDA Approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter - HMP Global Learning Network
Medtronic Earns Another PFA Approval, Is J&J Next in Line? - MD+DI
Nicholson Wealth Management Group LLC Invests $583,000 in Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic's Affera mapping and ablation system with Sphere-9 catheter gets FDA approval - Medical Device Network
Philips and Medtronic advocacy partnership aims to help accelerate access to life-saving treatments - BioSpace
Medtronic gains FDA nod for advanced ablation catheter - Investing.com
Medtronic (MDT) receives FDA approval of Affera Mapping and Ablation System and Sphere-9™ Catheter - StreetInsider.com
A new paradigm in electrophysiology: Medtronic receives FDA approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter - Medtronic
Boston Sci, Medtronic fare well in NICE review of remote monitoring - BioWorld Online
Medtronic's SWOT analysis: stock poised for growth amid challenges - Investing.com
Medtronic (NYSE:MDT) Reaches New 12-Month HighStill a Buy? - MarketBeat
Medtronic : receives CE Mark for Evolut™ FX+ TAVI system for treatment of symptomatic severe aortic stenosis - Marketscreener.com
Medtronic’s Prevail DCB pivotal trial receives FDA IDE approval - Medical Device Network
Coho Partners Ltd. Cuts Stake in Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.80%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):